| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.AMEPRE.2006.08.017 |
| P698 | PubMed publication ID | 17169712 |
| P2093 | author name string | Leonard J Paulozzi | |
| George W Ryan | |||
| P433 | issue | 6 | |
| P921 | main subject | poisoning | Q114953 |
| opioid | Q427523 | ||
| P304 | page(s) | 506-511 | |
| P577 | publication date | 2006-12-01 | |
| P1433 | published in | American Journal of Preventive Medicine | Q4744265 |
| P1476 | title | Opioid analgesics and rates of fatal drug poisoning in the United States | |
| P478 | volume | 31 |
| Q40480845 | A Randomized Controlled Trial of an Emergency Department Intervention for Patients with Chronic Noncancer Pain. |
| Q36302851 | A Review of Potential Adverse Effects of Long-Term Opioid Therapy: A Practitioner's Guide |
| Q44345855 | A population pharmacokinetic and pharmacodynamic modelling approach to support the clinical development of RBP-6000, a new, subcutaneously injectable, long-acting, sustained-release formulation of buprenorphine, for the treatment of opioid dependenc |
| Q37154848 | Abuse-deterrent opioid formulations: are they a pipe dream? |
| Q36554029 | An Epidemiologic Study of Pediatric Poisoning; a Six-month Cross-sectional Study |
| Q50612125 | An update on oxycodone: lessons for death investigators in Australia. |
| Q35487128 | Antinociceptive and cytotoxic activities of an epiphytic medicinal orchid: Vanda tessellata Roxb |
| Q38830845 | Assessing the impact of prescribing directives on opioid prescribing practices among Veterans Health Administration providers |
| Q35489297 | Benzodiazepine dependence among multidrug users in the club scene |
| Q58141108 | Characterizing the geographic variation and risk factors of fatal prescription opioid poisoning in New Hampshire, 2003–2007 |
| Q38033571 | Chronic pain and addiction: challenging co-occurring disorders |
| Q34667957 | Clustering of opioid prescribing and opioid-related mortality among family physicians in Ontario |
| Q39183960 | Cohort Study of the Impact of High-Dose Opioid Analgesics on Overdose Mortality |
| Q37067857 | Collaboration or coercion? Partnering to divert prescription opioid medications |
| Q50767264 | Commentary on Kurdyak et al. (2012): Methadone and other opioids - need for coordinated prescribing. |
| Q52316881 | Comparative Rates of Mortality and Serious Adverse Effects Among Commonly Prescribed Opioid Analgesics. |
| Q35084232 | Computational opioid prescribing: a novel application of clinical pharmacokinetics |
| Q35803135 | Concurrent use of alcohol and sedatives among persons prescribed chronic opioid therapy: prevalence and risk factors. |
| Q44342890 | Considering prescription opioid-related harms in the population: response to commentaries |
| Q37566058 | Continuous opioid treatment for chronic noncancer pain: a time for moderation in prescribing |
| Q33379960 | Correlates of illicit methadone use in New York City: a cross-sectional study. |
| Q45163779 | Danger in your pill bottle? |
| Q37872347 | Definitions related to the use of pharmaceutical opioids: extramedical use, diversion, non-adherence and aberrant medication-related behaviours |
| Q35075407 | Depression, chronic pain, and suicide by overdose: on the edge |
| Q27026097 | Determinants of increased opioid-related mortality in the United States and Canada, 1990-2013: a systematic review |
| Q37003866 | Determination of oxycodone, noroxycodone and oxymorphone by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry in human matrices: in vivo and in vitro applications |
| Q38398103 | Development and evaluation of a record linkage protocol for Utah's Controlled Substance Database. |
| Q36117657 | Distribution of naloxone for overdose prevention to chronic pain patients |
| Q58089295 | Diversion and misuse of pharmaceutical stimulants among illicit drug users |
| Q50169719 | Do medical marijuana laws reduce addictions and deaths related to pain killers? |
| Q39068529 | Do more robust prescription drug monitoring programs reduce prescription opioid overdose? |
| Q34411964 | Efficacy and tolerability of oxycodone in moderate-severe cancer-related pain: A meta-analysis of randomized controlled trials |
| Q90132341 | Enhancement of Opioid Antinociception by Nicotine |
| Q34984833 | Epidemiologic trends and geographic patterns of fatal opioid intoxications in Connecticut, USA: 1997-2007. |
| Q36113128 | Epidemiology of Spine Care: The Back Pain Dilemma |
| Q28534694 | Estimating the prevalence of opioid diversion by "doctor shoppers" in the United States |
| Q38996167 | Examining Fatal Opioid Overdoses in Marion County, Indiana |
| Q40032001 | Exposure to medicines among patients admitted for hip fracture and the case-fatality rate at 1 year: a longitudinal study |
| Q34158623 | Geographic information systems and pharmacoepidemiology: using spatial cluster detection to monitor local patterns of prescription opioid abuse |
| Q36430979 | Geographic variation in opioid prescribing in the U.S. |
| Q38670195 | Health outcomes associated with illicit prescription opioid injection: A systematic review |
| Q36319037 | Hot spots in mortality from drug poisoning in the United States, 2007-2009. |
| Q50492838 | How does use of a prescription monitoring program change medical practice? |
| Q90467524 | How increasing medical access to opioids contributes to the opioid epidemic: Evidence from Medicare Part D |
| Q37501624 | Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-Related Death Rates |
| Q36253355 | Inability to access buprenorphine treatment as a risk factor for using diverted buprenorphine. |
| Q44330077 | Increased adolescent opioid use and complications reported to a poison control center following the 2000 JCAHO pain initiative |
| Q33901433 | Increasing poisoning mortality rates in the United States, 1999-2006 |
| Q36176509 | Is Admission Serum Sodium Concentration a Clinical Predictor for the Outcome of Therapy in Critically Ill Poisoned Patients? |
| Q37397052 | Latent class analysis of non-opioid dependent illegal pharmaceutical opioid users in Ohio |
| Q35606850 | Long-term chronic opioid therapy discontinuation rates from the TROUP study |
| Q24598228 | Long-term opioid treatment of chronic nonmalignant pain: unproven efficacy and neglected safety? |
| Q33677848 | Long-term use of opioids for complex chronic pain |
| Q34167321 | Lumbar MR imaging and reporting epidemiology: do epidemiologic data in reports affect clinical management? |
| Q37030946 | Managing pain in high-risk patients within a patient-centered medical home |
| Q34634366 | Measuring pain medication expectancies in adults treated for substance use disorders |
| Q38870014 | Metabolomics of methadone: clinical and forensic toxicological implications and variability of dose response. |
| Q37363455 | Methadone: a new old drug with promises and pitfalls |
| Q92800141 | More than pills: alternative adjunct therapies to improve comfort in hospitalised patients |
| Q51806625 | Mortality associated with illegal drug use among adults in the United States. |
| Q37220737 | Motives for medical misuse of prescription opioids among adolescents |
| Q34602811 | National study of discontinuation of long-term opioid therapy among veterans |
| Q47755593 | Nonmedical use of pain medications in dental patients |
| Q42329954 | Opening the black box of inpatient opioid prescribing |
| Q56761492 | Opioid Discussion in the Twittersphere |
| Q38586633 | Opioid Prescribing Laws and Emergency Department Guidelines for Chronic Non-Cancer Pain in Washington State |
| Q36808956 | Opioid Prescribing at Hospital Discharge Contributes to Chronic Opioid Use. |
| Q44346905 | Opioid harm reduction strategies: focus on expanded access to intranasal naloxone |
| Q28397248 | Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis |
| Q37592812 | Opioid prescribing by multiple providers in Medicare: retrospective observational study of insurance claims |
| Q24630037 | Opioid prescriptions for chronic pain and overdose: a cohort study |
| Q37686941 | Opioid utilization and opioid-related adverse events in nonsurgical patients in US hospitals |
| Q59811940 | Opioid-Related Harms: Simplistic Solutions to the Crisis Ineffective and Cause Collateral Damage |
| Q37151876 | Opioids for chronic non-cancer pain: a protocol for a systematic review of randomized controlled trials |
| Q38152801 | Opioids in headache |
| Q37161503 | Oxycodone is associated with dose-dependent QTc prolongation in patients and low-affinity inhibiting of hERG activity in vitro |
| Q52298675 | Oxycodone poisoning: not just the 'usual suspects'. |
| Q90301853 | Perceived health, medical, and psychiatric conditions in individual and dual-use of marijuana and nonprescription opioids |
| Q24627422 | Personalized medicine and opioid analgesic prescribing for chronic pain: opportunities and challenges |
| Q37735281 | Pharmacokinetics of intranasal crushed OxyContin and intravenous oxycodone in nondependent prescription opioid abusers |
| Q42941168 | Policy implications of marked reversals of population life expectancy caused by substance use. |
| Q37460853 | Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone |
| Q37218709 | Prescription drug monitoring and drug overdose mortality |
| Q44336151 | Prescription drug monitoring programs and death rates from drug overdose |
| Q42198663 | Prescription histories and dose strengths associated with overdose deaths |
| Q36922546 | Prescription opioid abuse: challenges and opportunities for payers |
| Q33726016 | Prescription opioid use among addictions treatment patients: nonmedical use for pain relief vs. other forms of nonmedical use. |
| Q34117350 | Prescription opioid use among disabled Medicare beneficiaries: intensity, trends, and regional variation |
| Q40391620 | Prescription opioids, abuse and public health in Canada: is fentanyl the new centre of the opioid crisis? |
| Q36959466 | Propoxyphene and the risk of out-of-hospital death |
| Q99635813 | Recent changes in trends of opioid overdose deaths in North America |
| Q89998147 | Responses among substance abuse treatment providers to the opioid epidemic in the USA: Variations in buprenorphine and methadone treatment by geography, operational, and payment characteristics, 2007-16 |
| Q33965233 | Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: The TROUP Study |
| Q36660835 | Safety Issues Regarding Prescription Opioids |
| Q30457489 | Screening for substance abuse risk in cancer patients using the Opioid Risk Tool and urine drug screen |
| Q40194129 | Source of prescription drugs used nonmedically in rural and urban populations |
| Q36728665 | The Impact of Opioids on Cardiac Electrophysiology |
| Q40789824 | The Proliferation of Dosage Thresholds in Opioid Prescribing Policies and Their Potential to Increase Pain and Opioid-Related Mortality |
| Q28084160 | The complexity model: a novel approach to improve chronic pain care |
| Q37982103 | The diversion and misuse of pharmaceutical stimulants: what do we know and why should we care? |
| Q33779667 | The effects of opioids and opioid analogs on animal and human endocrine systems |
| Q39190148 | The impact of opioid prescription dose and duration during a workers compensation claim, on post-claim continued opioid use: A retrospective population-based study |
| Q37638777 | The influence of propoxyphene withdrawal on opioid use in veterans |
| Q88553874 | The opioid oxycodone use-dependently inhibits the cardiac sodium channel NaV 1.5. |
| Q44336215 | The prescription drug epidemic in the United States: a perfect storm |
| Q43524570 | The use of prescription monitoring programs to reduce opioid diversion and improve patient safety |
| Q48901094 | Toxicology and characteristics of fatal oxycodone toxicity cases in New South Wales, Australia 1999-2008. |
| Q34602766 | Treatment outcomes for prescription drug misusers: the negative effect of geographic discordance |
| Q36319074 | Trends and geographic patterns in drug-poisoning death rates in the U.S., 1999-2009. |
| Q40714291 | Trends and sex differences in prescription opioid deaths in British Columbia, Canada. |
| Q58325647 | Trends in Educational Inequalities in Drug Poisoning Mortality: United States, 1994-2010 |
| Q34173073 | Trends in high-dose opioid prescribing in Canada |
| Q35758775 | Trends in long-term opioid therapy for chronic non-cancer pain |
| Q35496564 | Trends in opioid use and dosing among socio-economically disadvantaged patients. |
| Q35396863 | Trends in prevalent and incident opioid receipt: an observational study in Veterans Health Administration 2004-2012. |
| Q35219129 | Trends in the prescription of opioids for adolescents with non-cancer pain |
| Q28396625 | Understanding the rural-urban differences in nonmedical prescription opioid use and abuse in the United States |
| Q43408473 | Unintentional injury deaths among adult Finns in 1971–2008 |
| Q37180212 | Use and Misuse of Opioids in Maine: Results From Pharmacists, the Prescription Monitoring, and the Diversion Alert Programs. |
| Q45841597 | Use of strong opioids for chronic non-cancer pain: a retrospective analysis at a pain centre in Singapore |
| Q28481410 | Using poison center exposure calls to predict methadone poisoning deaths |
| Q33910463 | Using spatial analysis to demonstrate the heterogeneity of the cardiovascular drug-prescribing pattern in Taiwan |
| Q39204538 | Vital signs: variation among States in prescribing of opioid pain relievers and benzodiazepines - United States, 2012. |
| Q38181184 | Would legalizing illicit opioids reduce overdose fatalities? Implications from a natural experiment |
| Q37387341 | Zebrafish: a model for the study of addiction genetics |
Search more.